Computational modelling suggests that the FLG Ser742Tyr variant enhances binding to BACE1, the β-site APP-cleaving enzyme critical for amyloid-β generation, supporting a barrier–amyloid axis linking epidermal dysfunction to AD [70]. Here, BACE1 is linked to Alzheimer disease.